Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide

Asian J Surg. 2017 Jan;40(1):61-65. doi: 10.1016/j.asjsur.2013.07.012. Epub 2013 Aug 23.

Abstract

Extracranial and meningeal seeding of glioblastoma multiforme is rare. We report herein a case of glioblastoma in a 41-year-old man who underwent surgical resection, concomitant chemoradiotherapy (CCRT) and seven courses of adjuvant chemotherapy with temozolomide. The patient then complained of intermittent severe lower back pain and gait disturbance. Imaging studies demonstrated that although the intracranial residual tumors were well-controlled by the treatment, meningeal seeding involving the brainstem and spinal cord was present. The patient died 2 months after the diagnosis of spinal seeding. This case illustrates the need for consideration of extracranial metastasis if a patient is symptomatic, even if the intracranial tumor appears responsive to treatment. We suggested that the prophylactic craniospinal irradiation may be considered in patients at high risk of meningeal seeding immediately after surgery.

Keywords: glioblastoma multiforme; meningeal seeding; spinal; temozolomide.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Brain Neoplasms / pathology*
  • Brain Neoplasms / therapy
  • Chemoradiotherapy, Adjuvant*
  • Dacarbazine / analogs & derivatives*
  • Dacarbazine / therapeutic use
  • Fatal Outcome
  • Glioblastoma / secondary*
  • Glioblastoma / therapy
  • Humans
  • Male
  • Meningeal Neoplasms / secondary*
  • Neoplasm Seeding*
  • Temozolomide

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide